ANSM — authorised 8 February 2018
- Marketing authorisation holder: Novo Nordisk A/S
- Status: approved
ANSM authorised Ozempic on 8 February 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. ANSM authorised it on 8 February 2018.
Novo Nordisk A/S holds the French marketing authorisation.